Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approachesTheodoros Karantanos, Timothy C. Thompson|Oncogene|2013Cited by 879
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Nizar M. Tannir, Luigi Perelli et al.|Cancer Cell|2020Cited by 142
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody V. Vykoukal, Timothy C. Thompson, Johannes F. Fahrmann et al.|Nature Communications|2020Cited by 83
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration‐resistant prostate cancer modelsYong Luo, Timothy C. Thompson|International Journal of Cancer|2017Cited by 50
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Timothy C. Thompson|Oncotarget|2016Cited by 29